Table 2.
Standardized beta coefficient | p-value | |
---|---|---|
Lipid panel | ||
Total cholesterol, mg/dl | 0.259 | 0.005 |
LDL-C, mg/dl | 0.086 | 0.353 |
HDL-C, mg/dl | 0.395 | <0.001 |
Triglycerides, mg/dl | 0.065 | 0.487 |
Cholesterol ratio (total/HDL-C) | −0.184 | 0.046 |
TG/HDL-C ratio | −0.042 | 0.655 |
Apo-AI, ng/ml | −0.121 | 0.194 |
Apo-AII, ng/ml | −0.148 | 0.110 |
Apo-B, ng/ml | −0.170 | 0.066 |
Apo-CII, ng/ml | −0.104 | 0.262 |
Apo-CIII, ng/ml | −0.136 | 0.143 |
Apo-E, ng/ml | −0.118 | 0.204 |
Baseline demographics | ||
Age, years | 0.003 | 0.975 |
Waist size, cm | −0.136 | 0.142 |
Weight, kg | −0.228 | 0.013 |
Height, cm | −0.164 | 0.077 |
BMI, kg/m2 | −0.164 | 0.075 |
CRP, μg/ml | −0.061 | 0.510 |
CD4+ T cell count, cells/mm3 | −0.032 | 0.730 |
FRS score | −0.184 | 0.046 |
FRS class | −0.186 | 0.044 |
Lipid-lowering medications | 0.077 | 0.406 |
Metabolic assessment | ||
Fasting glucose, mg/dl | −0.208 | 0.024 |
Fasting insulin, mg/dl | −0.139 | 0.134 |
Matsuda indexa | 0.218 | 0.029 |
NMR spectroscopy | ||
VLDL particle (VLDL-P) conc., nmol/liter | ||
Total VLDL-P | 0.127 | 0.170 |
Large VLDL-P | 0.021 | 0.820 |
Medium VLDL-P | 0.172 | 0.063 |
Small VLDL-P | 0.029 | 0.756 |
LDL particle (LDL-P) conc., nmol/liter | ||
Total LDL-P | −0.052 | 0.579 |
Large LDL-P | 0.165 | 0.074 |
Small LDL-P | −0.198 | 0.031 |
HDL particle (HDL-P) conc., μmol/liter | ||
Total HDL-P | 0.399 | <0.001 |
Large HDL-P | 0.337 | <0.001 |
Medium HDL-P | 0.400 | <0.001 |
Small HDL-P | −0.129 | 0.164 |
IDL Particle conc., nmol/liter | ||
Total IDL-P | 0.189 | 0.041 |
Mean particle size, nm | ||
VLDL | 0.003 | 0.971 |
LDL | 0.174 | 0.059 |
HDL | 0.253 | 0.006 |
N=101.
p-value<0.05.
The standardized beta coefficient is based on a one standard deviation of change in the exposure on the outcome and provides context to each variable's contribution to HDL efflux variance.
conc., concentration; CRP, C-reactive protein; LDL, low-density lipoprotein; HDL, high-density lipoprotein; VLDL, very-low-density lipoprotein; IDL, intermediate-density lipoprotein; TG, triglycerides; Apo, apolipoprotein; FRS, Framingham Risk Score.